Virios Therapeutics (NASDAQ: VIRI ) stock is falling on Monday after the development-stage biotechnology company announced the pricing of a public offering for its shares. Virios Therapeutics is selling 8.5 million shares of VIRI stock at a price of 20 cents per share.